Diagnosis and Management of Pulmonary Hypertension in the Modern Era: Insights from the 6th World Symposium

Abstract

Abstract The past 20 years have seen major advances in the diagnosis and management of pulmonary hypertension, a disease associated with significant morbidity and mortality. The 6th World Symposium in Pulmonary Hypertension (WSPH) took place in February 2018 and attempted to consolidate the current knowledge in the field into practical recommendations to help prioritize an action plan to improve patient outcomes and identify future research directions. In this review, we will summarize the highlights of the 6th WSPH proceedings, including revisions to the hemodynamic definitions and classification of the various types of pulmonary hypertension, genetic advances, approaches to risk stratification, and updated treatment algorithms.

Keywords

• Genetics
• Hemodynamics
• Pulmonary hypertension
• Pulmonary vascular disease
• Risk stratification
• Screening